Top Gainers: The Best-Performing North American Stocks and What Drove Them
October 14, 2026 | ATN Trade & Finance
In a week where hot inflation data hammered tech and growth stocks broadly, the biggest gains have come almost entirely from M&A announcements — with a handful of healthcare names benefiting from a sector rotation on Wednesday's CPI session.
The Month's Biggest Winner: Bumble (BMBL) +134%
Bumble has been the top-performing North American stock in October, gaining more than 134% month-to-date after Reuters reported the company is exploring a potential sale and has hired Morgan Stanley to run the process. No buyer has been named publicly, and no deal value has been disclosed. Shares surged as much as 15% on the initial Reuters report before partially fading, with further accumulation pushing month-to-date gains to their current level as buyers position ahead of a potential premium.
M&A Premiums Dominate the Leaderboard
Three of the next four top performers this month are also acquisition targets. Pacira BioSciences (PCRX) is up approximately +45% month-to-date after Viatris agreed to acquire the non-opioid pain management company for $1.65 billion ($36.50 per share) in cash. Option Care Health (OPCH) gained approximately +38% on the Clayton, Dubilier & Rice and McKesson buyout at roughly $5.8 billion in enterprise value. RXO is up approximately +34% after C.H. Robinson agreed to acquire the truck brokerage for an implied $30.25 per share — a 29% premium to the prior close — with C.H. Robinson citing $300 million in annual cost savings through its Lean AI operating model.
Wednesday's Session: Healthcare Leads a Down Market
On October 14, with the S&P 500 and Nasdaq both falling sharply on the hot CPI print, healthcare was the standout sector, gaining 2.44% while information technology fell 3.00%. The top session gainers included AstraZeneca (AZN) +4.29%, Merck (MRK) +4.09%, Eli Lilly (LLY) +3.90% — partly driven by Phase 1 trial enthusiasm with Prelude Therapeutics — and Pfizer +3.89%. Arrowhead Pharmaceuticals (ARWR) was among the standouts, gaining nearly 5% in premarket after releasing clinical data for ARO-MAPT, its experimental Alzheimer's treatment. BlackRock (BLK) added 3.87% on a Q3 earnings beat.
Canadian Names
Among Canadian-listed or Canadian stocks, the month's top performers include Greenfire Resources (GFR) +16.5% in energy, Docebo (DCBO) +15.8% in technology, and Shopify (SHOP) +15.7%, the last benefiting from continued e-commerce sector re-rating.
What this means for investors: The concentration of top gainers around acquisition targets reflects elevated M&A activity and confirms that deal premiums — not earnings beats — are driving the biggest single-name moves this month. Healthcare's defensive outperformance on the CPI day is consistent with the broader rotation out of rate-sensitive growth stocks and into sectors less exposed to higher-for-longer rates.
Sources: